Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Boston Scientific Hedges Bets In Drug-Coated Stents With Quanam Buy

This article was originally published in The Gray Sheet

  • News

Executive Summary

Boston Scientific's expansion of its drug-coated coronary stent R&D program through acquisition of Quanam could accelerate its European market entry by up to six months, the firm says.

You may also be interested in...



Medtronic Broadens Drug Delivery Options With EndoBionics Purchase

Medtronic's equity investment in privately held EndoBionics for injectable drug delivery technology complements Medtronic's existing drug-eluting stent platform

Medtronic Broadens Drug Delivery Options With EndoBionics Purchase

Medtronic's equity investment in privately held EndoBionics for injectable drug delivery technology complements Medtronic's existing drug-eluting stent platform

Boston Scientific Gains Distal Protection Market Entry With EPI's Filterwire

Boston Scientific's $75 mil. acquisition of Embolic Protection, Inc. provides an immediate entry into the vascular distal protection market.

Table

View full table

Related Content

Medtech Insight
Medtech Insight
Tags:
Latest Headlines

Medtronic Launches Remote Live-Stream Surgery, New AI Capabilities

News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR

GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health

FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility

See All
UsernamePublicRestriction

Register

MT014551

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By